Global Ablation Devices market is expected to grow at a CAGR of 10.61% during the forecast period 2017–2023 to aggregate $26.4 billion by 2023

Factors such as rise in geriatric population, increase in minimally invasive ablation procedures, increase in disposable income, growing awareness about office-based ablation procedures, increasing demand for medical lasers in various ablation techniques, and shift towards minimal and non-invasive procedures are expected to drive the market growth during the forecast period.

According to Infoholic Research, adoption of ablation devices in treating tissue related chronic disorders such as tumors and removal of small and large tissue has enabled surgeons to surgically remove or destroy the tissue by transferring heat. The ablation catheters are widely adopted in tissue ablation technique as they enhance the procedural versatility, are sensor enabled, and provide significant clinical outcome during the procedure. Radiofrequency ablation, microwave ablation, cryoablation, laser-based ablation, ultrasound ablation, hydrothermal, and EBRT are the types of systems used in ablation procedures. These procedures are performed by an experienced electrophysiologist under image-guided modalities such as CT and MRI. The cost of tissue ablation procedure is directly proportional to the size of the tissue/tumor and the number of probes required for the surgery. The popularity and growing awareness about ablation techniques will contribute to the revenue of the ablation device market.

The products such as MAESTRO 4000 Cardiac Ablation System, Cardioblate iRF Irrigated Radiofrequency Surgical Ablation System, Ethicon Endo-Surgery Generator, AtriCure Ablation Sensing Unit, BLAZER PRIME Temperature Ablation Catheter, Cardioblate CryoFlex Surgical Ablation Probes, THERMOCOOL Bi-Directional Catheter and PlasmaBlade Soft Tissue Dissection Devices are some of the branded products that have shown best results and are in high demand in the market. According to Infoholic Research, the “Global Ablation Devices” market is expected to grow at a CAGR of 10.61% during the forecast period 2017–2023 to touch an aggregate of $26.4 billion by 2023.

The market is analyzed based on three segments – product types, end-users, and regions. The product type covers generators/electrosurgical units, ablation catheters, and consumables, and the regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). In North America, the US and Canada are set to be the leading countries owing to the highest number of ablation procedures performed in 2016. Europe is set to be the second leading region and held more than 26% of the market share in 2016. The UK, Germany, and France are among the top three leading countries in Europe in terms of revenue with advancement in technology and anticipated launch of new products. In Asia Pacific, India and China are the most attractive countries for the players and holds tremendous business opportunities. The ROW is set to be an emerging market in the next 5–6 years.

The product areas covered in the report are generators/electrosurgical units, ablation catheters, and consumables. The consumables segment is the leading contributor accounting for 47% of the total ablation devices market. The use of consumables is maximum as most of the ablation procedures require them in every procedural step performed during the treatment. The increased adoption of energy-based devices, increase in demand for minimally invasive ablation procedures, and increasing application of radiofrequency devices in chronic conditions are owing to the high demand for consumables in the market. Generators are the second largest revenue contributor but have a moderate growth rate as most of the developed countries have already purchased electrosurgical units. These devices/systems are expensive and require installation and upgrading owing to high capital investment initially. The emerging countries are expected to purchase new generators/electrosurgical units to adopt newer ablation techniques and offer advanced treatment for various chronic diseases by different tissue ablation procedures. The factors such as high cost, lack of skilled surgeons, and stringent regulatory approval of devices in the market will hamper the market growth. These emerging markets are potential markets and are expected to see a significant change in treating chronic diseases as they have a large pool of patients. The ablation devices market is expected to be on a positive year on year growth rate as the ablation procedures are expected to significantly grow during the forecast period.

“Ablation devices are helpful in treating severe chronic conditions where medicines are ineligible for the individual in certain medical cases. The advantage of minimal and non-invasive procedures has attracted the individuals to adopt ablation procedures as they have a shorter duration of procedural time and do not require long hospital stay. The advances in robotics have enabled surgeons to perform procedures easily under multiple image guided scanner such as CT and MRI; this has allowed achieving better results with minimal risk and complications. However, the cost of ablation treatment remains a primary concern to most of the patients, which is challenging to the market. The shift towards minimal and non-invasive procedures is expected to boost the market growth.” – Victor Mukherjee, Assistant Manager (Research – Healthcare) at Infoholic Research